Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MYSTEP1: Mesenchymal Stem Cells in Pediatric Living-Donor Liver Transplantation
NCT02957552Phase 1Unknown
- Sponsor
- University Hospital Tübingen
- Start
- Mar 2017
- Primary completion
- Dec 2019
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of mesenchymal stem cells in liver failure, sponsored by University Hospital Tübingen. Primary endpoints: Number of participants with MYSTEP-score grade 3 and grade 2 at 28 days, Number of participants with occurrence of any severe adverse events at 2 years and 1 more. Status: unknown.
02
Drugs
mesenchymal stem cells
03
Conditions
liver failure
Beyond the preview
Go deeper on NCT02957552.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02957552.